TIDMODX

RNS Number : 1870O

Omega Diagnostics Group PLC

08 June 2022

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

PDMR/Director Dealing

Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition and Global Health products, announces that, following the general meeting held on 6 June 2022 and Admission on 8 June 2022, the following Directors participated in the Fundraising and their resultant holdings are detailed in the table below.

 
 Director             Board Position    Number of       Amount (GBP)   Resultant   Resultant 
                                         Subscription                   holding     percentage 
                                         Shares at                                  holding of 
                                         the Issue                                  Enlarged 
                                         Price                                      Issued Share 
                                                                                    Capital 
 Simon Douglas(1)     Chairman          500,000         2 0,000        500,000     0.21% 
                     ----------------  --------------  -------------  ----------  -------------- 
 Jag Grewal(2)        CEO               500,000         20,000         735,746     0.31% 
                     ----------------  --------------  -------------  ----------  -------------- 
 Chris Lea(3)         CFO               500,000         20,000         500,000     0.21% 
                     ----------------  --------------  -------------  ----------  -------------- 
                      Non-Executive 
 Jeremy Millard(4)     Director         500,000         20,000         1,025,000   0.43% 
                     ----------------  --------------  -------------  ----------  -------------- 
 

Capitalised terms not otherwise defined in the text of this announcement have the meanings given to them in the Company's circular dated 13 May 2022.

Contacts:

 
 Omega Diagnostics Group PLC                                            www.omegadx.com 
 Jag Grewal, Chief Executive Officer                                    via Walbrook PR 
 Chris Lea, Chief Financial Officer 
 
 finnCap Ltd                                                         Tel: 020 7220 0500 
 Geoff Nash/Edward Whiley/George Dollemore (Corporate 
  Finance) 
 Alice Lane/ Harriet Ward (ECM) 
 
 Walbrook PR Limited                         Tel: 020 7933 8780 or omega@walbrookpr.com 
 Paul McManus                                                        Mob: 07980 541 893 
 Lianne Applegarth                                                   Mob: 07584 391 303 
 Sam Allen                                                           Mob: 07502 558 258 
 
 

About Omega Diagnostics Group PLC

Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 70 countries and specialise in the areas of health and nutrition and global health.

www.omegadx.com

Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                               1) Simon Douglas 
                                          2) Jag Grewal 
                                          3) Chris Lea 
                                          4) Jeremy Millard 
     ----------------------------  ---------------------------------- 
 2    Reason for the notification 
     ---------------------------------------------------------------- 
 a)   Position/status                    1) Chairman 
                                          2) Chief Executive Officer 
                                          3) Chief Financial Officer 
                                          4) Non-Executive Director 
     ----------------------------  ---------------------------------- 
 b)   Initial notification          Initial Notification 
       /Amendment 
     ----------------------------  ---------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ---------------------------------------------------------------- 
 a)   Name                          Omega Diagnostics Group Plc 
     ----------------------------  ---------------------------------- 
 b)   LEI                           2138007U9P4BTZTYIR92 
     ----------------------------  ---------------------------------- 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
     ---------------------------------------------------------------- 
 a)   Description of                Ordinary Shares of 4 pence each 
       the financial instrument, 
       type of instrument            ISIN: GB00B1VCP282 
       Identification 
       code 
     ----------------------------  ---------------------------------- 
 b)   Nature of the transaction     Purchase of Shares 
     ----------------------------  ---------------------------------- 
 c)   Price(s) and volume(s)              Price(s)   Volume(s) 
                                      1)   GBP0.04     500,000 
                                      2)   GBP0.04     500,000 
                                      3)   GBP0.04     500,000 
                                      4)   GBP0.04     500,000 
     ----------------------------  ---------------------------------- 
 d)   Aggregated information        N/A - single transaction for 
       -Aggregated volume            each Director or PCA 
       - Price 
     ----------------------------  ---------------------------------- 
 e)   Date of the transaction        6 May 2022 
     ----------------------------  ---------------------------------- 
 f)   Place of the transaction      London Stock Exchange (AIM) 
     ----------------------------  ---------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBKFBQBBKDAAK

(END) Dow Jones Newswires

June 08, 2022 08:48 ET (12:48 GMT)

Omega Diagnostics (LSE:ODX)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024 Haga Click aquí para más Gráficas Omega Diagnostics.
Omega Diagnostics (LSE:ODX)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024 Haga Click aquí para más Gráficas Omega Diagnostics.